Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 23, 2023 - Issue 9
Submit an article Journal homepage
609
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Are monoclonals the way forward to prevent or to treat ventilator-associated pneumonia in the intensive care unit?

Ana Catalina Hernandez Padillaa Inserm, Limoges, France;b Réanimation Polyvalente, CHU Dupuytren, Limoges, France;c Inserm UMR 1092 and Université of Limoges, Limoges, FranceORCID Iconhttps://orcid.org/0000-0003-3464-7294View further author information
ORCID Icon,
Sylvain Meyerc Inserm UMR 1092 and Université of Limoges, Limoges, FranceORCID Iconhttps://orcid.org/0000-0001-7957-6093View further author information
ORCID Icon,
CH Van Werkhovend Department of Epidemiology and Health Economics, UMCU, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-0626-4635View further author information
ORCID Icon,
Marlieke EA de Krakere Département de Médecine, Geneva University Hospitals and Faculty of Medicine, Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-0903-8614View further author information
ORCID Icon &
Bruno Françoisa Inserm, Limoges, France;b Réanimation Polyvalente, CHU Dupuytren, Limoges, France;c Inserm UMR 1092 and Université of Limoges, Limoges, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2531-1652View further author information
ORCID Icon
Pages 861-866 | Received 17 May 2023, Accepted 21 Jul 2023, Published online: 29 Jul 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

List of abbreviations

ICU=

Intensive care unit

LRT=

Lower respiratory tract

mAb=

Monoclonal antibody

VAP=

Ventilator-associated pneumonia

Declaration of interest

B Francois reports consulting fees from Aridis and AstraZeneca. M de Kraker has received support from the IMI2/EU/EFPIA Joint Undertaking PrIMAVeRa, grant no 101034420. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.